Lewison Grant, Hussain Shoaib Fahad, Guo Ping, Harding Richard, Mukherji Deborah, Sittah Ghassan Abu, Aggarwal Ajay, Fouad Fouad, Bhoo-Pathy Nirmala, Shamieh Omar, Torode Julie, Kutluk Tezer, Sullivan Richard
King's College London, Institute for Cancer Policy, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Conflict and Health Research Group, School of Security Studies, King's College London, London SE1 9RT, UK.
Ecancermedicalscience. 2020 Aug 28;14:1094. doi: 10.3332/ecancer.2020.1094. eCollection 2020.
The 57 countries of the Organisation of Islamic Cooperation (OIC) are experiencing rapid increases in their burden of cancer. The First Ladies Against Cancer meeting at the 2016 OIC meeting in Istanbul committed to the importance of cancer control and the need for more evidence to support national cancer control planning (NCCP). Strong research systems are a crucial aspect of NCCP, but few data exist to support policy-makers across this political grouping.
We identified all cancer research papers from OIC countries in the Web of Science from 2008 to 2017 with a filter based on journal names and title words, with high precision and recall. We analysed the country outputs, the cancer sites investigated, the types of research, sources of funding and the citations to the papers.
There were 49,712 cancer research papers over this period. The leading countries in terms of output were Turkey, Iran, Egypt and Malaysia, but the most cited papers were from Qatar, Indonesia and Saudi Arabia. International collaboration was low, except in Qatar and the United Arab Emirates. The site-specific cancers accounting for most research were breast and blood, correlating with their disease burden in the OIC countries, but lung, cervical and oesophageal cancers were relatively under-researched. Most funding from within the OIC countries was from their own university sector.
Cancer is seriously under-researched in most of the OIC countries. This will undermine the ability of these countries and OIC as a whole to deliver on better cancer control for their populations. New policies, OIC leadership and funding are urgently needed to address this situation.
伊斯兰合作组织（OIC）的57个成员国的癌症负担正在迅速增加。在2016年于伊斯坦布尔举行的OIC会议上，抗癌第一夫人会议强调了癌症控制的重要性以及获取更多证据以支持国家癌症控制规划（NCCP）的必要性。强大的研究体系是NCCP的关键要素，但针对这个政治集团内的政策制定者，几乎没有数据可供支持。
我们在科学网中识别出2008年至2017年来自OIC国家的所有癌症研究论文，通过基于期刊名称和标题词汇的筛选，实现了高精度和高召回率。我们分析了国家产出、所研究的癌症部位、研究类型、资金来源以及论文的被引情况。
在此期间共有49,712篇癌症研究论文。产出方面领先的国家是土耳其、伊朗、埃及和马来西亚，但被引次数最多的论文来自卡塔尔、印度尼西亚和沙特阿拉伯。除了卡塔尔和阿拉伯联合酋长国，国际合作程度较低。占研究比重最大的特定部位癌症是乳腺癌和血液癌，这与它们在OIC国家的疾病负担相关，但肺癌、宫颈癌和食管癌的研究相对较少。OIC国家内部的大部分资金来自其本国的大学部门。
在大多数OIC国家，癌症研究严重不足。这将削弱这些国家以及整个OIC为其民众提供更好癌症控制的能力。迫切需要新政策、OIC的领导作用和资金来应对这种情况。
